Evidence map›Paper›PMID 34271989›Full record

ArticleJournal of medical case reports2021

Acute motor-sensory axonal polyneuropathy variant of Guillain-Barre syndrome complicating the recovery phase of coronavirus disease 2019 infection: a case report.

Ahmed Maseh Haidary, Sarah Noor, Esmatullah Hamed, Tawab Baryali, Soma Rahmani, Maryam Ahmad, Farahnaz Erfani, Hashmatullah Azimi, Habib Ul Rahman Habib, Gul Ahmad Tahiri and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Ahmed Maseh HaidaryDepartment of Pathology and Laboratory Medicine, French medical Institute for Mothers and Children, Kabul, Afghanistan. ahmedmaseh.haidary@fmic.org.af.ORCID http://orcid.org/0000-0002-4554-8024
Sarah NoorDepartment of Medicine, Jumhoriat Hospital, Afghan Ministry of Health, Kabul, Afghanistan.
Esmatullah HamedNeurology Unit, Department of Medicine, French Medical Institute for Mothers and Children, Kabul, Afghanistan.
Tawab BaryaliDepartment of Quality, French Medical Institute for Mothers and Children, Kabul, Afghanistan.
Soma RahmaniDepartment of Pathology and Laboratory Medicine, French medical Institute for Mothers and Children, Kabul, Afghanistan.
Maryam AhmadDepartment of Pathology and Laboratory Medicine, French medical Institute for Mothers and Children, Kabul, Afghanistan.
Farahnaz ErfaniDepartment of Pathology and Laboratory Medicine, French medical Institute for Mothers and Children, Kabul, Afghanistan.
Hashmatullah AzimiDepartment of Pathology and Laboratory Medicine, French medical Institute for Mothers and Children, Kabul, Afghanistan.
Habib Ul Rahman HabibNeurology Unit, Department of Medicine, French Medical Institute for Mothers and Children, Kabul, Afghanistan.
Gul Ahmad TahiriNeurology Unit, Department of Medicine, French Medical Institute for Mothers and Children, Kabul, Afghanistan.
Ramin SaadaatDepartment of Pathology and Laboratory Medicine, French medical Institute for Mothers and Children, Kabul, Afghanistan.
Abdul Sami IbrahimkhilDepartment of Pathology and Laboratory Medicine, French medical Institute for Mothers and Children, Kabul, Afghanistan.
Esmatullah EsmatDepartment of Pathology and Laboratory Medicine, French medical Institute for Mothers and Children, Kabul, Afghanistan.
Haider Ali MalakzaiDepartment of Pathology and Laboratory Medicine, French medical Institute for Mothers and Children, Kabul, Afghanistan.
Kabul Medical University · AF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe novel coronavirus, since its first identification in China, in December 2019, has shown remarkable heterogeneity in its clinical behavior. It has affected humans on every continent. Clinically, it has affected every organ system. The outcome has also been variable, with most of the older patients showing grave outcomes as compared with the younger individuals. Here we present a rare and severe variant of Guillain-Barre syndrome that complicated the disease in recovery phase. CASE PRESENTATION: A 60-year-old Afghan man, who had been recovering from symptoms related to novel coronavirus associated disease, presented with sudden onset of progressive muscle weakness and oxygen desaturation. Electrophysiological workup confirmed the diagnosis of Guillain-Barre syndrome, and early institution of intravenous immunoglobulin resulted in complete resolution.

conclusionGuillain-Barre syndrome has recently been reported in many patients diagnosed with novel coronavirus associated disease. While clinical suspicion is mandatory to guide towards an effective diagnostic workup, early diagnosis of this complication and timely institution of therapeutic interventions are indispensable and lifesaving.

Indexed as

COVID-19Guillain-Barre SyndromeChinaHumansImmunoglobulins, IntravenousMaleMiddle AgedSARS-CoV-2Immunoglobulins, IntravenousAMSANCOVID-19GBSRecovery phase

Identifiers

PMID34271989
PMCPMC8283095
OpenAlexW3180190313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.